HU886797D0 - Process for production of medical compositions against caries of bones - Google Patents
Process for production of medical compositions against caries of bonesInfo
- Publication number
- HU886797D0 HU886797D0 HU886797A HU679788A HU886797D0 HU 886797 D0 HU886797 D0 HU 886797D0 HU 886797 A HU886797 A HU 886797A HU 679788 A HU679788 A HU 679788A HU 886797 D0 HU886797 D0 HU 886797D0
- Authority
- HU
- Hungary
- Prior art keywords
- bones
- production
- compositions against
- medical compositions
- against caries
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8704436A SE8704436D0 (en) | 1987-11-13 | 1987-11-13 | USE OF ANTI-SECRETARY SUBSTANCES FOR NEW INDICATIONS |
Publications (2)
Publication Number | Publication Date |
---|---|
HU886797D0 true HU886797D0 (en) | 1990-05-28 |
HUT51894A HUT51894A (en) | 1990-06-28 |
Family
ID=20370204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU886797A HUT51894A (en) | 1987-11-13 | 1988-10-27 | Process for production of medical compositions against caries of bones |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0353262A1 (en) |
JP (1) | JPH02502188A (en) |
AU (1) | AU2720388A (en) |
DK (1) | DK329289A (en) |
HU (1) | HUT51894A (en) |
SE (1) | SE8704436D0 (en) |
WO (1) | WO1989004178A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8629781D0 (en) * | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
KR20030097610A (en) * | 1997-07-22 | 2003-12-31 | 머크 앤드 캄파니 인코포레이티드 | Composition for inhibiting bone resorption |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
ES2924478T3 (en) | 2012-03-15 | 2022-10-07 | Boehringer Ingelheim Vetmedica Gmbh | Formulation of pharmaceutical tablets for the veterinary medical sector, method of production and use thereof |
EP3865120A1 (en) | 2013-07-19 | 2021-08-18 | Boehringer Ingelheim Vetmedica GmbH | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
CN110721164B (en) | 2013-12-04 | 2024-09-17 | 勃林格殷格翰动物保健有限公司 | Improved pharmaceutical compositions of pimobendan |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
US4220653A (en) * | 1979-01-24 | 1980-09-02 | Vivino A Earl | Administration of cimetidine to reduce appetite and facilitate weight loss in persons suffering from excessive weight |
US4256743A (en) * | 1979-02-22 | 1981-03-17 | President And Fellows Of Harvard College | Inhibition of bone resorption with H1 -blocking antihistamines |
IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
-
1987
- 1987-11-13 SE SE8704436A patent/SE8704436D0/en unknown
-
1988
- 1988-10-27 AU AU27203/88A patent/AU2720388A/en not_active Withdrawn
- 1988-10-27 EP EP88910155A patent/EP0353262A1/en not_active Withdrawn
- 1988-10-27 JP JP63509275A patent/JPH02502188A/en active Pending
- 1988-10-27 WO PCT/SE1988/000574 patent/WO1989004178A1/en not_active Application Discontinuation
- 1988-10-27 HU HU886797A patent/HUT51894A/en unknown
-
1989
- 1989-07-03 DK DK329289A patent/DK329289A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK329289D0 (en) | 1989-07-03 |
AU2720388A (en) | 1989-06-01 |
EP0353262A1 (en) | 1990-02-07 |
WO1989004178A1 (en) | 1989-05-18 |
SE8704436D0 (en) | 1987-11-13 |
JPH02502188A (en) | 1990-07-19 |
HUT51894A (en) | 1990-06-28 |
DK329289A (en) | 1989-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT47022A (en) | Process for production of medical compositions | |
HUT50190A (en) | Process for production of n-substituated 1-dezoxinogimiricin and 1-dezoxi-manno-nogimiricin and medical compositions containing them | |
HUT47561A (en) | Process for production of 3-aryloxi-3-substituated propanamids and medical compositions containing them | |
HUT45895A (en) | Process for production of serotomin antagonic compounds and medical preparatives containing such compositions | |
HUT46221A (en) | Process for production of medical compositions containing alphusosine | |
HUT44941A (en) | Process for producing stabile pharmaceutical compositions containing stimulating factor for colonies of granulocites | |
PL275089A1 (en) | Method of obtaining novel pharmaceutical compositions | |
HUT42953A (en) | Process for production of medical compositions | |
HUT46912A (en) | Process for production of 1,4-dihydro-piridines and medical preparatives containing such compositions | |
HUT51485A (en) | Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions | |
HUT45894A (en) | Process for production of shaped medical plaster | |
HUT49893A (en) | Process for production of new crystallic formation and medical compositions containing it | |
HUT51138A (en) | Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine | |
HUT37354A (en) | Process for production of medical plaster | |
HUT45982A (en) | Process for production of microlide compositions and medical preparatives containing such compositions | |
HUT50166A (en) | Process for production of substituated 3,4-dihydro-rh-benzopiranes and medical compositions containing them | |
HUT42950A (en) | Process for production of medical compositions with delayed effect | |
HUT51247A (en) | Process for production of aryl-zyanguananidins and medical compositions containing them | |
HUT53291A (en) | Process for production of medical compositions applicable for treatment of inflammation of diarthrosis | |
HU9200821D0 (en) | Process for the production of medical preparation containing tioredoxine | |
HUT47267A (en) | Process for production of new pirasoline-derivatives and medical compositions containing them | |
HU886797D0 (en) | Process for production of medical compositions against caries of bones | |
HUT45968A (en) | Process for production of derivatives of substituated amin and medical compositions containing these compounds | |
HUT50165A (en) | Process for production of alkyl substituated n-benzopiramil lactanes and medical compositions containing them | |
HUT50167A (en) | Process for production of derivatives of tetrasole and medical compositions containing them |